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Synthesis of 3-Amino-1-benzothiophene-1,1-diones by Alkyne
Directed Hydroarylation and 1/N→3/C-Sulfonyl Migration
Ivan Bernar,[a] Daniel Blanco-Ania,[a] Sophie J. Stok,[a] Lia Sotorríos,[b]
Enrique Gómez-Bengoa,*[b] and Floris P. J. T. Rutjes*[a]
Abstract: A completely regioselective and highly stereoselec-
tive palladium-catalyzed intramolecular hydroarylation of ar-
enesulfonyl ynamines to benzothiazoles was developed. The
presence of an electron-withdrawing group on the triple bond
of the sulfonyl ynamine was crucial for the success of the reac-
Introduction
Sulfonyl ynamines have recently emerged as a privileged class
of ynamides.[1] They are stable compounds, readily prepared[2]
and easy to handle. In addition, the polarized alkyne system of
sulfonyl ynamines shows excellent reactivity in a wide variety
of reactions featuring π-acid catalysis,[3] metal-catalyzed cycliza-
tions,[4] cycloadditions[5] and rearrangements[6] for the synthesis
of complex nitrogen-containing heterocycles and natural prod-
ucts. With the idea of extending the chemistry of these
ynamines, we envisioned that arenesulfonyl ynamines 1 could
be used as simple precursors for a single step, atom-efficient
synthesis of 1,2-benzothiazole-1,1-diones, key elements of
diverse biologically active compounds and useful reagents in
organic synthesis (Scheme 1).[7]
Considering that compounds 1 react in the presence of alk-
ynophilic transition metals usually through π-activation of the
triple bond, we anticipated that initial alkyne coordination
might direct an aromatic ortho-C–H activation followed by a
stereocontrolled intramolecular hydroarylation (pathway A,
Scheme 1), similar to that of N-alkynyl indoles developed by
Park et al.[8] or alkynyl aryl ethers developed by Hiyama et al.[9]
Moreover, excitation of the obtained benzothiazolediones 2
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tion and our mechanistic studies suggest an alkyne-directed
5-exo-dig cyclization pathway. The products easily underwent
photoinduced rearrangement to 3-amino-1-benzothiophene-
1,1-diones (up to 35 % yields after two steps).
Scheme 1. Syntheses and applications of 1,2-benzothiazole-1,1-diones and 3-
amino-1-benzothiophene-1,1-diones.
with light could trigger a [1,3]sigmatropic rearrangement of
the sulfonyl group by S–N bond cleavage[10] followed by colli-
gation to 3-amino-1-benzothiophene-1,1-diones 3 (pathway B,
Scheme 1).[11] In particular, our interest in these compounds
was awakened because they are potential crop protecting
agents, and therefore beneficial for the ECHONET program we
are part of.[12] To the best of our knowledge, alkyne-directed 5-
exo-dig cyclizations of arenesulfonyl ynamines to 1,2-benzothi-
azole-1,1-diones and its following rearrangement to 3-amino-1-
benzothiophene-1,1-diones have not been yet explored.
Results and Discussion
We initially investigated the behavior of sulfonyl ynamine 1a in
the presence of alkynophilic transition metals and Brønsted ac-
ids (Table 1; for detailed information on the reaction optimiza-
tion, see the Supporting Information). The reaction took place
only with palladium-based catalysts. Thus, sulfonyl ynamine 1a
was converted to products (E/Z)-2a, 3, 4 and 5 in the presence
of Pd(OAc)2 (5 mol-%) in toluene at 100 °C for 18 h (Table 1,
entry 1). The (E)-exocyclic alkylidene product 2a was isolated in
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Table 1. Reaction optimization.
Ratio of products [%][a]
Entry Catalyst Additive 1a 2a 3 4 5 E/Z-ratio[a] Yield (E)-2a [%][b]
1 Pd(OAc)2 27 35 33 3 2 82:18 21
2 Pd(PPh3)4 30 10 58 2 0 90:10 7
3 Pd(PPh3)4 HOAc 43 23 17 3 14 92:8 14
4 Pd(OAc)2 Zn 23 37 38 2 0 85:15 20
5 Pd(OAc)2 NaOAc[c] 28 14 58 0 0 85:15 8
6 Pd(OAc)2/PCy3 13 48 36 0 3 90:10 27
7 Pd(OAc)2/P(p-tol)3 10 51 35 0 4 98:2 37
[a] Reaction conditions: 1a (1.0 mmol), Pd catalyst (5 mol-%), phosphine ligand (10 mol-%), additive (10 mol-%), PhMe (10.0 mL), 100 °C for 18 h. [a] Based
on the 1H NMR spectrum of the crude. [b] Isolated yield. [c] NaOAc (2.0 equiv.).
21 % yield after purification of the crude mixture by neutral
silica-gel column chromatography.
The structure of (E)-2a was unambiguously determined by
NMR spectroscopy and X-ray crystallography. This reaction also
showed degradation of sulfonyl ynamine 1a under the reaction
conditions forming N-phenyl sulfonamide 3, which was the
main byproduct of the ynamide cyclization. Compound 3 re-
acted further with 1a to form Michael adduct 4, which was
successfully isolated after purification. Furthermore, sulfonyl
ynamine 1a underwent partial hydrogenation of the triple bond
to yield sulfonyl enamine 5 in a trace amount.[13] The reaction
also took place in the presence of palladium(0), albeit in a much
lower conversion compared to Pd(OAc)2 (entries 2 and 3). The
use of Pd(OAc)2 and Zn, a catalytic system developed by Hi-
yama et al. for the cyclization of alkynyl aryl ethers,[9] had no
influence on the yield of 2a (entry 4). These initial studies
showed that formation of benzothiazoledione 2a took place
without any further additives (e.g., NaOAc, entry 5). Finally, ad-
dition of phosphine ligands promoted the cyclization. Bulky li-
gands led in general to higher yields and better ratios of the
stereoisomers (entries 6 and 7).
Although the yields are relatively low, this unprecedented
intramolecular hydroarylation reaction is completely regioselec-
tive and highly stereoselective: (E)-exocyclic 1,2-benzothiazole-
1,1-dione 2a is the major isomer with an E/Z-ratio of up to 98:2,
confirmed by NOE studies in all cases.
With these results in hand, we focused our attention on the
scope and limitations of the reaction varying the substituents
on the alkyne terminus (R1), on the aromatic ring of the sulfon-
amide group (R2) and on the nitrogen (R3) for the hydroaryl-
ation of sulfonyl ynamines 1a–k (Scheme 2). Notably, the pres-
ence of an electron-withdrawing group on the triple bond, e.g.,
ester or ketone, was essential for the success of the hydroaryl-
ation. Thus, sulfonyl ynamines with a ketone showed similar
reactivity to sulfonyl ynamine 1a proceeding with exclusive
regioselectivity and excellent stereoselectivity (2b–2c). In stark
contrast, when the reaction was performed with sulfonyl
ynamines 1d–1f (R = H, SiMe3, Ph) no cyclization was detected
and only decomposition to 3 was observed. Changing the con-
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ditions (solvent, temperature, Pd catalyst, addition of base) did
not lead to products 2d–2f either.
Scheme 2. Scope of sulfonyl ynamines for intramolecular hydroarylation. Re-
action conditions: 1 (1.0 mmol), Pd(OAc)2 (5 mol-%), P(p-tol)3 (10 mol-%),
PhMe (10.0 mL), 100 °C for 18 h. [a] Isolated yield. [b] Based on the 1H NMR
spectrum of the crude mixture.
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Next, a series of electronically different sulfonyl ynamines
were employed for this transformation. To our delight, we ob-
served no significant difference in the reaction efficiency when
changing the substituents at the aryl group of the sulfonamide.
1,2-Benzothiazole-1,1-diones (2g–i) were obtained in compara-
ble yields and also with complete regioselectivity and with ex-
cellent stereoselectivity. Finally, sulfonyl ynamines 1j and 1k
were subjected to the reaction conditions to compare the reac-
tivity of compounds with different substitution on the nitrogen.
Compound 1j formed product 2j in 31 % yield and compound
1k resulted in the formation of a mixture of 2k (>99:1 E/Z ratio)
and 6 in 26 and 10 % yield, respectively.[14]
For a better understanding of the reaction mechanism, we
investigated the reaction pathway with DFT calculations (Fig-
ure 1). The most logical mechanistic scenario for the reaction
of sulfonyl ynamine 1l and Pd(OAc)2 would involve coordination
of the PdII species to the substrate, as in 7, followed by an
alkyne-directed concerted deprotonation-metalation sequence
(CDM).[15] Thus, calculations indicate transition state TS1 in
which one of the acetate groups is acting both as a κ2 ligand
and as a base. The proton abstraction presents the highest acti-
vation barrier within the catalytic cycle (22.6 kcal/mol), and
therefore should be considered as the rate-determining step of
the reaction. Additionally, ortho-C–H activation in TS1 proceeds
much slower for the alkyne–H and alkyne–SiMe3 substructures
(24.5 and 24.6 kcal/mol, for 1d and 1e, respectively) compared
to the corresponding alkyne–CO2Me substructure 1l. The differ-
ence between these barrier values is >2.5 kcal/mol correspond-
ing to more than 100 times slower reaction rate, which is in
agreement with the experimental results. Consequently, the in-
termediate 8 performs a carbopalladation to the CC triple bond
through TS2, leading to intermediate 9. Also, this step was pre-
dicted to be a few kcal/mol higher for sulfonyl ynamines 1d
and 1e (16.0 and 14.2 kcal/mol respectively) than for sulfonyl
ynamine 1l (11.2 kcal/mol). Further protonation of the “push-
pull” alkenyl–PdII species 9 with acetic acid forms an enol inter-
mediate 10, with almost free rotation around the exocyclic
C–C bond. We found that the enol structure 10 lies 12.9 kcal/
mol higher in energy than palladium species 9, confirming the
Figure 1. Computed pathway for cyclization of 1l. Free energies (298 K) with respect to starting materials are shown in kcal/mol.
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feasibility of this or related isomerization processes. The final
protodemetalation with acetic acid renders the major product
(E)-2a and recovers the active PdII-acetate species.
Our DFT calculations further reveal that the (E)-isomer is the
most stable isomer [2.5 kcal/mol Lower in energy than the (Z)-
isomer, Scheme 3]. To validate this result, (E)-2a and (Z)-2a were
subjected independently to the same experimental conditions.
We observed the formation of an 85:15 E/Z mixture of isomers
after 18 h of reaction time. These results suggest that the cycli-
zation of 1a might proceed in an exceptional stereoselective
manner (as proposed in Scheme 2), however the major product
further undergoes partial isomerization under the reaction con-
ditions.
Scheme 3. Equilibration between (E)- and (Z)-isomers of 2a. Free energies
(298 K) are shown in kcal/mol.
Finally, 1,2-benzothiazole-1,1-diones 2 underwent a previ-
ously unexplored photoinduced rearrangement to 3-amino-1-
benzothiophene-1,1-diones 12 while being irradiated with UV
light (300 nm; Scheme 4).
Thus, when either stereoisomer of 2a or the mixture of both
was exposed to irradiation at 50 °C for 24 h, a complete photo-
chemical conversion to 3-amino-1-benzothiophene-1,1-dione
12a was observed. Furthermore, to show the scope of this
transformation, several 1,2-benzothiazoledione derivatives were
subjected to the same reaction conditions. The corresponding
products 12b–12d were obtained in excellent yields in all cases.
The structure of the products was confirmed by selNOE spectro-
scopy and X-ray crystallography of 12a and 12d. We also pro-
pose a plausible mechanism on the basis of previously reported
photoinduced cleavage of sulfonamides.[7] This [1,3]sigmatropic
rearrangement entails a homolytic cleavage of the sulfonamide
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Scheme 4. Photochemical rearrangement of 1,2-benzothiazole-1,1-diones 2
to 3-amino-1-benzothiophene-1,1-diones 12. Reaction conditions: 2
(0.1 mmol), CH3CN (10.0 mL), hν (300 nm), 24 h. [a] Isolated yield.
S–N bond of 1,2-benzothiazoledione 2, followed by recombina-
tion of the resulting sulfinate radical with the C-terminus of
the enaminyl radical (13). Subsequent tautomerization of the
formed imine 14 results in 3-amino-1-benzothiophene-1,1-di-
one 12.
Conclusions
In summary, we have demonstrated a completely regioselective
and highly stereoselective intramolecular hydroarylation of sulf-
onyl ynamines. This method opens an easy access to benzothi-
azole heterocycles, valuable scaffolds in medicinal and organic
synthesis. Our mechanistic studies suggest an alkyne-directed
5-exo-dig intramolecular cyclization pathway, where the pres-
ence of an electron-withdrawing group at the triple bond was
key for the success of the reaction. Moreover, we have discov-
ered the first example of photoinduced rearrangement of 1,2-
benzothiazole-1,1-diones to form 3-amino-1-benzothiophene-
1,1-dione derivatives in excellent yields. Optimization studies
that broaden the synthetic scope and applications of the reac-
tion are currently under investigation.
Experimental Section
General Information: Reagents were obtained from commercial
suppliers and were used without purification. Standard syringe
techniques were applied for the transfer of dry solvents and air- or
moisture-sensitive reagents. All inert reactions were carried out un-
der a nitrogen atmosphere using flame-dried flasks. If stated, reac-
tions were performed in Biotage Initiator+ Microwave Synthesizer
under a nitrogen atmosphere. 1H and 13C NMR spectra were re-
corded at 298 K on a Varian Inova 400 MHz or Bruker 500 MHz
spectrometer in the solvent indicated. Chemical shifts are given in
parts per million (ppm) with respect to tetramethylsilane (δ =
0.00 ppm) as internal standard for 1H NMR; and CDCl3 (δ =
77.16 ppm) as internal standard for 13C NMR spectroscopy. Coupling
constants are reported as J values in Hertz (Hz). 1H NMR spectro-
scopic data are reported as follows: chemical shift (ppm), multiplic-
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ity (s = singlet, d = doublet, quint = quintet, t = triplet and combina-
tion of them), coupling constants (Hz) and integration. All NMR sig-
nals were assigned on the basis of 1H NMR, 13C NMR, gCOSY,
gHSQC, gHMBS and NOESY experiments. Mass spectra were re-
corded on a JEOL AccuTOF CS JMST100CS (ESI) mass spectrometer.
Automatic flash column chromatography was performed using
Biotage Isolera Spektra One, using SNAP cartridges (Biotage, 30–
100 μm, 60 Å), 10–50 g. Analysis by TLC was conducted on Silica
gel F254 (Merck KGaA) plates with detection by UV absorption (254
nm) where applicable, and by dipping into a solution of aqueous
KMnO4/Na2CO3/NaOH solution followed by charring at ca. 150 °C.
IR spectra were recorded on a Bruker Tensor 27 FTIR spectrometer.
General Procedure for the Synthesis of Sulfonamides: Sulfon-
amides 3 and S1–S5 were prepared by the literature procedure
reported by Murphy et al.[16] The sulfonyl chloride (11 mmol,
1.1 equiv.) was added to a solution of the amine (10 mmol, 1 equiv.)
and pyridine (950 mg, 12 mmol, 1.2 equiv.) in CH2Cl2 (30 mL) por-
tion-wise with stirring. The reaction mixture was then stirred at 23°
for 12 h before evaporation of CH2Cl2 and quenching with an aque-
ous NaOH solution (2 N, 100 mL). The aqueous solution was rinsed
with diethyl ether (2 × 50 mL) then acidified with concentrated HCl
and extracted with CH2Cl2 (3 × 50 mL). The combined organic wash-
ings were dried with sodium sulfate and concentrated in vacuo. The
obtained crude product was used directly in the next step without
further purification.
N-Phenylbenzenesulfonamide (S1): Sulfonamide S1 was prepared
from aniline (0.9 g, 10 mmol) and benzenesulfonyl chloride (1.9 g,
11 mmol) according to the general procedure and obtained in 90 %
yield as a white solid. 1H NMR [400 MHz, CDCl3]: δ = 6.58 (br. s, 1
H): δ = 7.02–7.09 (m, 2 H), 7.09–7.18 (m, 1 H), 7.20–7.29 (m, 2 H),
7.40–7.48 (m, 2 H), 7.50–7.58 (m, 1 H), 7.72–7.79 (m, 2 H) ppm. 13C
NMR [101 MHz, CDCl3]: δ = 121.6, 125.4, 127.3, 129.3, 129.7, 133.0,
136.5, 139.0 ppm. These data were in accordance to those reported
in the literature.[17]
4-Methyl-N-phenylbenzenesulfonamide (3): Sulfonamide 3 was
prepared from aniline (0.9 g, 10 mmol) and 4-methylbenzenesulf-
onyl chloride (2.1 g, 11 mmol) according to the general procedure
and obtained in 92 % yield as a white solid. 1H NMR [400 MHz,
CDCl3]: δ = 2.35 (s, 3 H), 6.61 (br. s, 1 H), 7.02–7.10 (m, 2 H), 7.12–
7.25 (m, 5 H), 7.62–7.68 (m, 2 H) ppm. 13C NMR [101 MHz, CDCl3]:
δ = 21.6, 121.5, 125.1, 127.5, 129.2, 129.6, 136.0, 136.4, 143.9 ppm.
These data were in accordance to those reported in the litera-
ture.[17]
4-Methoxy-N-phenylbenzenesulfonamide (S2): Sulfonamide S2
was prepared from aniline (0.9 g, 10 mmol) and 4-methoxy-
benzenesulfonyl chloride (2.3 g, 11 mmol) according to the general
procedure and obtained in 81 % yield as a white solid. 1H NMR
[400 MHz, CDCl3]: δ = 3.82 (s, 3 H), 6.70 (br. s, 1 H), 6.81–6.96 (m, 2
H), 7.03–7.15 (m, 3 H), 7.18–7.31 (m, 2 H), 7.59–7.78 (m, 2 H) ppm.
13C NMR [101 MHz, CDCl3]: δ = 55.7, 114.3, 121.6, 125.2, 129.4, 129.5,
130.7, 136.9, 163.2 ppm. These data were in accordance to those
reported in the literature.[17]
4-Nitro-N-phenylbenzenesulfonamide (S3): Sulfonamide S3 was
prepared from aniline (0.9 g, 10 mmol) and 4-nitrobenzenesulfonyl
chloride (2.4 g, 11 mmol) according to the general procedure and
obtained in 94 % yield as a light yellow solid. 1H NMR [400 MHz,
CDCl3]: δ = 6.02 (br. s, 1 H), 7.07–7.32 (m, 5 H), 7.89–7.93 (m, 2 H),
8.22–8.30 (m, 2 H) ppm. 13C NMR [101 MHz, CDCl3]: δ = 122.4, 124.3,
126.6, 128.7, 129.9, 135.2, 144.5, 150.3 ppm. These data were in
accordance to those reported in the literature.[18]
N-Benzyl-4-methylbenzenesulfonamide (S4): Sulfonamide S4
was prepared from benzylamine (1.07 g, 10 mmol) and 4-methyl-
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benzenesulfonyl chloride (2.1 g, 11 mmol) according to the general
procedure and obtained in 91 % yield as a white solid. 1H NMR
[400 MHz, CDCl3]: δ = 2.32 (s, 3 H), 4.02 (d, J = 6.5 Hz, 2 H), 6.74 (br.
t, J = 6.5 Hz, 1 H), 7.05–7.21 (m, 5 H), 7.27–7.31 (m, 2 H), 7.64–7.71
(m, 2 H) ppm. 13C NMR [101 MHz, CDCl3]: δ = 21.7, 48.3, 128.3,
128.4, 129.1, 129.5, 130.9, 139.1, 139.2, 144.3 ppm. These data were
in accordance to those reported in the literature.[19]
N,4-Dimethylbenzenesulfonamide (S5): Sulfonamide S5 was pre-
pared from methylamine hydrochloride (0.68 g, 10 mmol) and 4-
methylbenzenesulfonyl chloride (2.1 g, 11 mmol) according to the
general procedure and obtained in 89 % yield as brown oil. 1H NMR
[400 MHz, CDCl3]: δ = 2.42 (s, 3 H), 2.62 (d, J = 5.5 Hz, 3 H), 4.45 (br.
s, 1 H), 7.29–7.33 (m, 2 H), 7.70–7.76 (m, 2 H) ppm. 13C NMR
[101 MHz, CDCl3]: δ = 21.2, 29.5, 127.3, 129.8, 135.7, 143.3 ppm.
These data were in accordance to those reported in the litera-
ture.[20]
General Procedure for the Synthesis of 1,2-Dichlorovinyl Sulf-
onamides: 1,2-Dichlorovinyl sulfonamides S6–S11 were prepared
by the literature procedure reported by Anderson et al.[21] The sulf-
onamide (8 mmol, 1.0 equiv.) was added dropwise at 0 °C to a
suspension of sodium hydride (670 mg, 60 % dispersion in mineral
oil, 16.8 mmol, 2.1 equiv.) in DMF (30 mL) and the reaction mixture
was warmed to 23° in 2 h. Trichloroethene (800 μL, 8.8 mmol,
1.1 equiv.) was slowly added to this solution, which was after stirred
at 50 °C for 16 h. After cooling to 23°, the reaction mixture was
quenched with water (300 mL) and extracted with AcOEt (3 ×
50 mL). The combined organic washings were dried with sodium
sulfate, concentrated in vacuo and the crude residue was purified
by column chromatography as indicated. The E-configuration of the
obtained products including the new compounds was assigned
based on the 1H NMR spectra and X-ray crystallography data known
from the literature.[21]
N-[(E)-1,2-Dichlorovinyl]-N-phenylbenzenesulfonamide (S6):
Column chromatography (heptane/AcOEt, 40:1 → 10:1) afforded
product S6 as a yellow oil (72 %). RF (silica gel, heptane/AcOEt,
10:1): 0.34 (UV, KMnO4 solution). 1H NMR [400 MHz, CDCl3]: δ = 6.46
(s, 1 H), 7.30–7.39 (m, 5 H), 7.43–7.50 (m, 2 H), 7.58–7.63 (m, 1 H),
7.75–7.80 (m, 2 H) ppm. 13C NMR [101 MHz, CDCl3]: δ = 120.7, 128.6,
128.78, 128.79, 129.2, 129.4, 130.6, 133.6, 137.6, 138.5 ppm. FTIR:
ν˜ = 811, 1089, 1169, 1363, 1489, 2934, 3086 cm–1. HRMS (ESI-TOF)
m/z: [M + H]+ calcd. for C14H13Cl2NO2S 327.9966, found 327.9954.
N-[(E)-1,2-Dichlorovinyl]-4-methyl-N-phenylbenzenesulfon-
amide (S7): Column chromatography (heptane/AcOEt, 40:1→ 10:1)
afforded the product S7 as a white solid (91 %). RF (silica gel, hept-
ane/AcOEt, 1:1): 0.70 (UV, KMnO4 solution). 1H NMR [400 MHz,
CDCl3]: δ = 2.41 (s, 3 H), 6.46 (s, 1 H), 7.19–7.27 (m, 2 H), 7.30–7.39
(m, 5 H), 7.61–7.69 (m, 2 H) ppm. 13C NMR [101 MHz, CDCl3]: δ =
21.7, 120.5, 128.6, 128.8, 129.1, 129.3, 129.4, 130.7, 135.6, 137.7,
144.6 ppm. These data were in accordance to those reported in the
literature.[22]
N-[(E)-1,2-Dichlorovinyl]-4-methoxy-N-phenylbenzenesulfon-
amide (S8): Column chromatography (heptane/AcOEt, 40:1→ 10:1)
afforded the product S8 as a yellow oil (87 %). RF (silica gel, hept-
ane/AcOEt, 7:1): 0.23 (UV, KMnO4 solution). 1H NMR [400 MHz,
CDCl3]: δ = 3.86 (s, 3 H), 6.45 (s, 1 H), 6.86–6.98 (m, 2 H), 7.29–7.41
(m, 5 H), 7.65–7.73 (m, 2 H) ppm. 13C NMR [101 MHz, CDCl3]: δ =
55.6, 113.9, 120.4, 128.7, 129.0, 129.3, 130.0, 130.7, 130.9, 137.8,
163.6 ppm. FTIR: ν˜ = 809, 1089, 1160, 1261, 1361, 1489, 1594, 2945,
3085 cm–1. HRMS (ESI-TOF) m/z: [M + H]+ calcd. for C15H15Cl2NO3S
358.0071, found 358.0092.
N-[(E)-1,2-Dichlorovinyl]-4-nitro-N-phenylbenzenesulfonamide
(S9): Column chromatography (heptane/AcOEt, 20:1 → 2:1) af-
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forded the product S9 as a white solid (82 %). RF (silica gel, hept-
ane/AcOEt, 10:1): 0.11 (UV, KMnO4 solution). 1H NMR [400 MHz,
CDCl3]: δ = 6.51 (s, 1 H), 7.31–7.49 (m, 5 H), 7.81–7.99 (m, 2 H), 8.21–
8.40 (m, 2 H) ppm. 13C NMR [101 MHz, CDCl3]: δ = 121.3, 124.0,
128.7, 129.72, 129.77, 129.83, 129.84, 137.0, 144.1, 150.6 ppm. FTIR:
ν˜ = 685, 738, 1094, 1171, 1348, 1530, 3082, 3102 cm–1. HRMS (ESI-
TOF) m/z: [M + H]+ calcd. for C14H12Cl2N2O4S 372.9817, found
372.9834.
N-Benzyl-N-[(E)-1,2-dichlorovinyl]-4-methylbenzenesulfon-
amide (S10): Column chromatography (heptane/AcOEt, 40:1→ 4:1)
afforded the product S10 as a white solid (73 %). RF (silica gel, hept-
ane/AcOEt, 10:1): 0.23 (UV, KMnO4 solution). 1H NMR [400 MHz,
CDCl3]: δ = 2.47 (s, 3 H), 3.72–4.81 (br. s, 2 H), 6.27 (s, 1 H), 7.28–
7.34 (m, 5 H), 7.32–7.37 (m, 2 H), 7.80–7.86 (m, 2 H) ppm. 13C NMR
[101 MHz, CDCl3]: δ = 21.7, 52.0, 121.7, 128.23, 128.28, 129.3, 129.4,
129.8, 133.5, 135.3, 144.7 ppm. These data were in accordance to
those reported in the literature.[21]
N-[(E)-1,2-Dichlorovinyl]-N,4-dimethylbenzenesulfonamide
(S11): Column chromatography (heptane/ AcOEt 40:1 → 10:1) af-
forded the product S11 as brown oil (64 %). RF (silica gel, heptane/
AcOEt, 10:1): 0.13 (UV, KMnO4 solution). 1H NMR [400 MHz, CDCl3]:
δ = 2.45 (s, 3 H), 2.94 (s, 3 H), 6.39 (s, 1 H), 7.31–7.37 (m, 2 H), 7.79–
7.85 (m, 2 H) ppm. 13C NMR [101 MHz, CDCl3]: δ = 21.7, 37.9, 121.4,
127.8, 129.2, 129.5, 132.4, 143.2 ppm. FTIR: ν˜ = 693, 722, 1084, 1160,
1333, 1498, 2986, 3012 cm–1. HRMS (ESI-TOF) m/z: [M + H]+ calcd.
for C10H13Cl2NO2S 279.9966, found 279.9983.
General Procedure A for the Syntheses of Sulfonyl Ynamines:
Sulfonyl Ynamines 1a, 1d, 1e, 1g, 1h, 1i, 1j and 1k were prepared
by the literature procedure reported by Davies et al.[23] n-Butyllith-
ium (3.8 mL, 1.6 M in THF, 6 mmol, 2.1 equiv.) was slowly added to
a stirred solution of 1,2-dichlorovinyl sulfonamide (5 mmol,
1.0 equiv.) in THF (30 mL) under an argon atmosphere at –78 °C.
After stirring for 1 h, the lithium acetylide was treated with the
corresponding electrophile and stirred for 1 h at –78 °C. The mixture
was warmed to 23 °C and stirred for 2–3 h. The reaction mixture
was quenched with brine (100 mL) and extracted with Et2O (2 ×
50 mL). The combined organic washings were dried with sodium
sulfate, concentrated in vacuo and the crude residue was purified
by column chromatography as indicated.
General Procedure B for the Syntheses of Sulfonyl Ynamines:
Sulfonyl Ynamines 1b and 1c were prepared by the literature proce-
dure reported by Wolf et al.[24] Sulfonyl ynamine 1d (1.0 g,
3.7 mmol, 1.0 equiv.), CuI (70 mg, 0.37 mmol, 0.1 equiv.) and N,N-
diisopropylethylamine (1.5 mL, 7.4 mmol, 2.0 equiv.) were dissolved
in chloroform (20 mL) under a nitrogen atmosphere. After 30 min,
the acyl chloride (5.6 mmol, 1.5 equiv.) was added, and the mixture
was stirred until completion as determined by TLC. Solvent was
removed in vacuo and the crude residue was purified by column
chromatography as indicated.
General Procedure C for the Syntheses of Sulfonyl Ynamines:
Sulfonyl Ynamine 1f was prepared by the literature procedure re-
ported by Hsung et al.[25] Sulfonyl ynamine 1d (1.0 g, 3.7 mmol,
1.0 equiv.), iodobenzene (830 mg, 4.1 mmol, 1.1 equiv.) and
Pd(PPh3)4 (214 mg, 0.185 mmol, 0.05 equiv.) were dissolved in Et3N/
toluene mixture (2:1, 36 mL) under a nitrogen atmosphere. The so-
lution was stirred at 23 °C for 10 min, and CuI (11 mg, 0.06 mmol,
0.015 equiv.) was then added. After heating the reaction mixture at
60 °C for 12 h, the mixture was diluted with AcOEt, filtered through
a diatomaceous earth pad, and concentrated in vacuo. The resulting




(1a): Sulfonyl ynamine 1a was prepared according to general proce-
dure A using 1,2-dichlorovinyl sulfonamide S7 (1.7 g, 5.0 mmol).
The lithium acetylide was treated with freshly distilled ethyl chloro-
formate (714 μL, 7.5 mmol) at –78 °C for 15 min and at 23 °C for 2
h. Column chromatography (heptane/AcOEt, 40:1 → 10:1; silica gel
was washed with 1 % Et3N in heptane before being used for column
chromatography) afforded the product 1a as a white solid (82 %).
RF (silica gel, heptane/AcOEt, 10:1): 0.11 (UV, KMnO4 solution). 1H
NMR [400 MHz, CDCl3]: δ = 1.31 (t, J = 7.1 Hz, 3 H), 2.46 (s, 3 H),
4.24 (q, J = 7.1 Hz, 2 H), 7.16–7.23 (m, 2 H), 7.29–7.34 (m, 2 H), 7.34–
7.38 (m, 3 H), 7.58–7.67 (m, 2 H) ppm. 13C NMR [101 MHz, CDCl3]:
δ = 14.2, 21.8, 61.7, 66.6, 82.2, 126.5, 128.4, 129.3, 129.6, 130.0,
133.1, 137.5, 145.9, 154.8 ppm. These data were in accordance to
those reported in the literature.[23]
N-(4,4-Dimethyl-3-oxopent-1-yn-1-yl)-4-methyl-N-phenyl-
benzenesulfon-amide (1b): Sulfonyl ynamine 1b was prepared ac-
cording to general procedure B. The reaction with pivaloyl chloride
(690 μL, 6.6 mmol) was performed at 30 °C for 18 h. Column chro-
matography (toluene; silica gel was washed with 1 % Et3N in hept-
ane before being used for column chromatography) afforded the
product 1b as a light yellow oil (79 %). RF (silica gel, toluene): 0.32
(UV, KMnO4 solution). 1H NMR [400 MHz, CDCl3]: δ = 1.20 (s, 9 H),
2.40 (s, 3 H), 7.16–7.20 (m, 2 H), 7.24–7.28 (m, 2 H), 7.30–7.34 (m, 3
H), 7.53–7.59 (m, 2 H) ppm. 13C NMR [101 MHz, CDCl3]: δ = 21.6,
26.3, 44.5, 73.6, 89.1, 126.3, 128.3, 129.1, 129.3, 129.7, 133.2, 127.4,
145.6, 193.2 ppm. These data were in accordance to those reported
in the literature.[24]
4-Methyl-N-(3-oxo-3-phenylprop-1-yn-1-yl)-N-phenylbenzene-
sulfonamide (1c): Sulfonyl ynamine 1c was prepared according to
general procedure B. The reaction with benzoyl chloride (767 μL,
6.6 mmol) was performed at 30 °C for 24 h. Column chromatogra-
phy (heptane/AcOEt, 20:1 → 10:1; silica gel was washed with 1 %
Et3N in heptane before being used for column chromatography)
afforded the product 1c as a light yellow oil (86 %). RF (silica gel,
heptane/AcOEt, 10:1): 0.33 (UV, KMnO4 solution). 1H NMR [400 MHz,
CDCl3]: δ = 2.42 (s, 3 H), 7.25–7.29 (m, 4 H), 7.36–7.41 (m, 3 H), 7.47–
7.55 (m, 2 H), 7.60–7.65 (m, 3 H), 8.14–8.26 (m, 2 H) ppm. 13C NMR
[101 MHz, CDCl3]: δ = 21.7, 74.9, 90.2, 126.4, 128.2, 128.7, 129.2,
129.2, 129.5, 129.9, 132.9, 133.5, 136.9, 137.1, 145.9, 176.8 ppm.
These data were in accordance to those reported in the litera-
ture.[24]
N-Ethynyl-4-methyl-N-phenylbenzenesulfonamide (1d): Sulfonyl
ynamine 1d was prepared according to general procedure A using
1,2-dichlorovinyl sulfonamide S7 (1.7 g, 5.0 mmol). The lithium acet-
ylide was treated with water (10 mL) and the resulting mixture was
stirred at 23 °C for 2 h. Column chromatography (heptane/AcOEt,
20:1 → 10:1; silica gel was washed with 1 % Et3N in heptane before
being used for column chromatography) afforded the product 1d
as a light yellow oil (81 %). RF (silica gel, heptane/AcOEt, 10:1): 0.18
(UV, KMnO4 solution). 1H NMR [400 MHz, CDCl3]: δ = 2.44 (s, 3 H),
2.83 (s, 1 H), 7.23–7.34 (m, 7 H), 7.56–7.61 (m, 2 H) ppm. 13C NMR
[101 MHz, CDCl3]: δ = 21.7, 59.1, 75.8, 126.2, 128.2, 128.3, 129.0,
129.4, 132.7, 138.4, 145.0 ppm. These data were in accordance to
those reported in the literature.[26]
4-Methyl-N-phenyl-N-[(trimethylsilyl)ethynyl]benzenesulfon-
amide (1e): Sulfonyl ynamine 1e was prepared according to gen-
eral procedure A using 1,2-dichlorovinyl sulfonamide S7 (1.7 g,
5.0 mmol). The lithium acetylide was treated with trimethylsilyl
chloride (952 μL, 7.5 mmol) at –78 °C for 15 min and at 23 °C for
2 h. Column chromatography (heptane/AcOEt, 20:1; silica gel was
washed with 1 % Et3N in heptane before being used for column
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chromatography) afforded the product 1e as a white solid (52 %).
RF (silica gel, heptane/AcOEt, 10:1): 0.27 (UV, KMnO4 solution). 1H
NMR [400 MHz, CDCl3]: δ = 0.17 (s, 9 H), 2.45 (s, 3 H), 7.21–7.25 (m,
2 H), 7.26–7.30 (m, 2 H), 7.30–7.36 (m, 3 H), 7.54–7.60 (m, 2 H) ppm.
13C NMR [101 MHz, CDCl3]: δ = 0.16, 21.9, 73.4, 93.2, 126.3, 128.3,
128.6, 129.2, 129.5, 133.0, 138.7, 145.1 ppm. FTIR: ν˜ = 752, 834, 902,
1056, 1168, 1372, 1476, 1592, 2137, 2161, 2887, 3034 cm–1. HRMS
(ESI-TOF) m/z: [M + H]+ calcd. for C18H23NO2SSi 344.1141, found
344.1134.
4-Methyl-N-phenyl-N-(phenylethynyl)benzenesulfonamide (1f):
Sulfonyl ynamine 1f was prepared according to general procedure
C. Column chromatography (heptane/AcOEt, 20:1 → 10:1; silica gel
was washed with 1 % Et3N in heptane before being used for column
chromatography) afforded the product 1f as a light yellow solid
(80 %). RF (silica gel, heptane/AcOEt, 10:1): 0.27 (UV, KMnO4 solu-
tion). 1H NMR [400 MHz, CDCl3]: δ = 2.45 (s, 3 H), 7.27–7.36 (m, 9
H), 7.36–7.42 (m, 3 H), 7.61–7.65 (m, 2 H) ppm. 13C NMR [101 MHz,
CDCl3]: δ = 21.7, 70.6, 83.2, 122.7, 126.5, 126.3, 128.1, 128.32, 128.34,
129.0, 129.5, 131.4, 132.9, 139.0, 145.1 ppm. These data were in
accordance to those reported in the literature.[27]
Ethyl 3-(N-Phenylbenzenesulfonamido)propanoate (1g): Sulf-
onyl ynamine 1g was prepared according to general procedure A
using 1,2-dichlorovinyl sulfonamide S6 (1.6 g, 5.0 mmol). The lith-
ium acetylide was treated with freshly distilled ethyl chloroformate
(714 μL, 7.5 mmol) at –78 °C for 15 min and at 23 °C for 2 h. Column
chromatography (toluene; silica gel was washed with 1 % Et3N in
heptane before being used for column chromatography) afforded
the product 1g as a white solid (74 %). RF (silica gel, toluene): 0.35
(UV, KMnO4 solution). 1H NMR [400 MHz, CDCl3]: δ = 1.31 (t, J =
7.1 Hz, 3 H), 4.24 (q, J = 7.1 Hz, 2 H), 7.14–7.22 (m, 2 H), 7.30–7.41
(m, 3 H), 7.49–7.58 (m, 2 H), 7.64–7.73 (m, 1 H), 7.74–7.80 (m, 2 H)
ppm. 13C NMR [101 MHz, CDCl3]: δ = 14.2, 61.8, 66.5, 81.9, 126.6,
128.3, 129.27, 129.29, 129.5, 134.6, 135.8, 137.0, 154.0 ppm. FTIR:
ν˜ = 685, 726, 1088, 1123, 1204, 1372, 1702, 2218, 2982 cm–1. HRMS
(ESI-TOF) m/z: [M + H]+ calcd. for C17H17NO4S 330.0800, found
330.0812.
Ethyl 3-(4-Methoxy-N-phenylbenzenesulfonamido)propanoate
(1h): Sulfonyl ynamine 1h was prepared according to general pro-
cedure A using 1,2-dichlorovinyl sulfonamide S8 (1.8 g, 5.0 mmol).
The lithium acetylide was treated with freshly distilled ethyl chloro-
formate (714 μL, 7.5 mmol) at –78 °C for 15 min and at 23 °C for
2 h. Column chromatography (toluene; silica gel was washed with
1 % Et3N in heptane before being used for column chromatogra-
phy) afforded the product 1h as colorless oil (84 %). RF (silica gel,
toluene): 0.25 (UV, KMnO4 solution). 1H NMR [400 MHz, CDCl3]: δ =
1.30 (t, J = 7.1 Hz, 3 H), 3.88 (s, 3 H), 4.23 (q, J = 7.1 Hz, 2 H), 6.91–
7.03 (m, 2 H), 7.15–7.24 (m, 2 H), 7.3–7.40 (m, 3 H), 7.64–7.73 (m, 2
H) ppm. 13C NMR [101 MHz, CDCl3]: δ = 14.2, 55.8, 61.7, 66.6, 82.5,
114.4, 126.4, 127.2, 129.2, 129.5, 130.6, 137.2, 154.1, 164.4 ppm.
FTIR: ν˜ = 689, 1087, 1123, 1371, 1496, 1593, 1702, 2216, 2981 cm–1.




ate (15): Sulfonyl ynamine 1i and compound 15 were prepared
according to general procedure A using 1,2-dichlorovinyl sulfon-
amide S9 (1.9 g, 5.0 mmol). The lithium acetylide was treated with
freshly distilled ethyl chloroformate (714 μL, 7.5 mmol) at –78 °C for
15 min and at 23 °C for 3 h. Column chromatography (toluene; silica
gel was washed with 1 % Et3N in heptane before being used for
column chromatography) afforded the product 1i (42 %) and prod-
uct 15 (41 %) as white solids. Product 15 was a common side prod-
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uct during the course of the reaction.[28] Compound 1i: RF (silica
gel, toluene): 0.33 (UV, KMnO4 solution). 1H NMR [400 MHz, CDCl3]:
δ = 1.32 (t, J = 7.1 Hz, 3 H), 4.25 (q, J = 7.1 Hz, 2 H), 7.17–7.23 (m,
2 H), 7.36–7.46 (m, 3 H), 7.92–8.00 (m, 2 H), 8.33–8.42 (m, 2 H) ppm.
13C NMR [101 MHz, CDCl3]: δ = 14.1, 62.0, 66.7, 80.4, 124.5, 126.5,
129.7, 129.81, 129.84, 136.5, 140.9, 150.7, 153.6 ppm. FTIR: ν˜ = 690,
740, 854, 1086, 1126, 1184, 1206, 1348, 1533, 1593, 1706, 2223,
2925, 3107 cm–1. HRMS (ESI-TOF) m/z : [M + H]+ calcd. for
C17H16N2O6S 375.0651, found 375.0659. Compound 15: RF (silica
gel, toluene): 0.07 (UV, KMnO4 solution). 1H NMR [400 MHz, CDCl3]:
δ = 1.41 (t, J = 7.1 Hz, 3 H), 4.33 (q, J = 7.1 Hz, 2 H), 6.14 (s, 1 H),
7.11–7.16 (m, 2 H), 7.20–7.23 (m, 2 H), 7.24–7.27 (m, 2 H), 7.33–7.38
(m, 2 H), 7.40–7.45 (m, 2 H), 7.45–7.50 (m, 3 H), 7.52–7.57 (m, 1 H),
7.93–8.00 (m, 2 H), 8.09–8.18 (m, 2 H) ppm. 13C NMR [101 MHz,
CDCl3]: δ = 14.1, 61.6, 110.0, 117.5, 123.4, 124.1, 129.4, 129.6, 129.7,
129.93, 129.97, 129.99, 130.0, 136.0, 136.3, 139.9, 143.4, 144.2, 149.9,
150.4, 163.9 ppm. FTIR: ν˜ = 694, 740, 855, 1086, 1139, 1172, 1202,
1350, 1531, 1720, 3106 cm–1. HRMS (ESI-TOF) m/z: [M + H]+ calcd.
for C29H26N4O10S2 653.1012, found 653.1034.
Ethyl 3-(N,4-Dimethylbenzenesulfonamido)propanoate (1j):
Sulfonyl ynamine 1j was prepared according to general procedure
A using 1,2-dichlorovinyl sulfonamide S11 (1.4 g, 5.0 mmol). The
lithium acetylide was treated with freshly distilled ethyl chloro-
formate (714 μL, 7.5 mmol) at –78 °C for 15 min and at 23 °C for 2
h. Column chromatography (heptane/AcOEt, 20:1 → 10:1; silica gel
was washed with 1 % Et3N in heptane before being used for column
chromatography) afforded the product 1j as a white solid (71 %).
RF (silica gel, heptane/AcOEt, 1:1): 0.6 (UV, KMnO4 solution). 1H NMR
[400 MHz, CDCl3]: δ = 1.31 (t, J = 7.1 Hz, 3 H), 2.47 (s, 3 H), 3.17 (s,
3 H), 4.23 (q, J = 7.1 Hz, 2 H), 7.35–7.44 (m, 2 H), 7.78–7.92 (m, 2 H)
ppm. 13C NMR [101 MHz, CDCl3]: δ = 14.2, 21.8, 38.5, 61.6, 66.0,
83.5, 128.0, 130.2, 133.0, 145.8, 154.1 ppm. These data were in ac-
cordance to those reported in the literature.[29]
Ethyl 3-(N-Benzyl-4-methylbenzenesulfonamido)propanoate
(1k): Sulfonyl ynamine 1k was prepared according to general proce-
dure A using 1,2-dichlorovinyl sulfonamide S10 (1.8 g, 5.0 mmol).
The lithium acetylide was treated with freshly distilled ethyl chloro-
formate (714 μL, 7.5 mmol) at –78 °C for 15 min and at 23 °C for 2
h. Column chromatography (heptane/AcOEt, 40:1 → 10:1; silica gel
was washed with 1 % Et3N in heptane before being used for column
chromatography) afforded the product 1k as a white solid (87 %).
RF (silica gel, heptane/AcOEt, 10:1): 0.17 (UV, KMnO4 solution). 1H
NMR [400 MHz, CDCl3]: δ = 1.28 (t, J = 7.1 Hz, 3 H), 2.44 (s, 3 H),
4.18 (q, J = 7.1 Hz, 2 H), 4.62 (s, 2 H), 7.24–7.33 (m, 7 H), 7.68–7.75
(m, 2 H) ppm. 13C NMR [101 MHz, CDCl3]: δ = 14.2, 21.6, 55.3, 61.4,
68.1, 82.5, 127.6, 128.5, 128.6, 129.3, 129.7, 133.5, 134.1, 145.4, 153.9
ppm. These data were in accordance to those reported in the litera-
ture.[22]
Products of Palladium-Catalyzed Intramolecular Hydroarylation
of Sulfonyl Ynamine 1a: Sulfonyl ynamine 1a (343 mg, 1.0 mmol,
1.0 equiv.) was dissolved in toluene (10 mL) under a nitrogen at-
mosphere in a Biotage microwave vial (10.0–20.0 mL) equipped
with a magnetic stirr ing bar. Pd(OAc)2 (11 mg, 0.05 mmol,
0.05 equiv.) and tri(p-tolyl)phosphine (30 mg, 0.1 mmol, 0.1 equiv.)
were added at 23 °C. The vial was covered with a Teflon septum and
secured via a crimped aluminum cap. The reaction was irradiated
in a Biotage Initiator microwave at 100 °C for 18 h (30 second pre-
stir, Fixed Hold Time On, Low absorbance level). The reaction mix-
ture was quenched with brine (50 mL) and extracted with AcOEt
(2 × 20 mL). The resulting organic washings were dried with sodium
sulfate, concentrated in vacuo and the crude residue was purified
by column chromatography (toluene; silica gel was washed with
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1 % Et3N in heptane before being used for column chromatogra-
phy).
Ethyl (E)-2-[5-Methyl-1,1-dioxo-2-phenyl-1,2-benzothiazol-
3(2H)-ylidene]acetate [(E)-2a]: RF (silica gel, toluene): 0.33 (UV,
KMnO4 solution). 1H NMR [400 MHz, CDCl3]: δ = 1.26 (t, J = 7.1 Hz,
3 H), 2.57 (s, 3 H), 4.18 (q, J = 7.1 Hz, 2 H), 5.11 (s, 1 H), 7.47–7.51
(m, 2 H), 7.54–7.62 (m, 4 H), 7.82 (d, J = 7.9 Hz, 1 H), 9.23 (quint, J =
0.8 Hz, 1 H) ppm. 13C NMR [101 MHz, CDCl3]: δ = 14.2, 22.2, 60.5,
97.0, 120.9, 127.4, 129.8, 130.36, 130.39, 130.43, 130.5, 131.0, 133.1,
144.8, 146.2, 166.1 ppm. FTIR: ν˜ = 714, 902, 1089, 1174, 1302, 1512,
1635, 1737, 2992 cm–1. HRMS (ESI-TOF) m/z: [M + H]+ calcd. for
C18H19NO4S 344.0957, found 344.0966.
Ethyl (Z)-2-[5-Methyl-1,1-dioxo-2-phenyl-1,2-benzothiazol-
3(2H)-ylidene]acetate [(Z)-2a]: RF (silica gel, toluene): 0.28 (UV,
KMnO4 solution). 1H NMR [400 MHz, CDCl3]: δ = 1.01 (t, J = 7.1 Hz,
3 H), 2.54 (s, 3 H), 3.66 (q, J = 7.1 Hz, 2 H), 5.83 (s, 1 H), 7.36–7.49
(m, 5 H), 7.55 (m, J = 8.0, 1.2, 0.6 Hz, 1 H), 7.62 (quint, J = 0.6 Hz, 1
H), 7.79 (d, J = 8.0 Hz, 1 H) ppm. 13C NMR [101 MHz, CDCl3]: δ =
13.9, 22.0, 60.4, 93.0, 121.5, 122.0, 126.9, 128.6, 128.9, 129.5, 130.2,
133.1, 134.9, 140.2, 144.9, 164.0 ppm. FTIR: ν˜ = 693, 907, 1082, 1145,
1266, 1327, 1494, 1635, 1708, 3029 cm–1. HRMS (ESI-TOF) m/z: [M +
H]+ calcd. for C18H19NO4S 344.0957, found 344.0943.
4-Methyl-N-Phenylbenzenesulfonamide (3): The spectroscopic
data were identical to those reported above.
Ethyl 3,3-Bis(4-methyl-N-phenylbenzenesulfonamido)acrylate
(4): RF (silica gel, toluene): 0.06 (UV, KMnO4 solution). 1H NMR
[400 MHz, CDCl3]: δ = 1.39 (t, J = 7.1 Hz, 3 H), 2.30 (s, 3 H), 2.38 (s,
3 H), 4.33 (q, J = 7.1 Hz, 2 H), 6.09 (s, 1 H), 6.86–6.94 (m, 4 H), 7.06–
7.12 (m, 2 H), 7.12–7.19 (m, 6 H), 7.26–7.33 (m, 2 H), 7.33–7.40 (m,
3 H), 7.42–7.48 (m, 1 H) ppm. 13C NMR [101 MHz, CDCl3]: δ = 14.1,
21.5, 21.6, 61.1, 115.5, 127.3, 128.18, 128.23, 128.93, 128.97, 129.0,
129.4, 129.5, 130.0, 130.2, 135.1, 136.0, 136.8, 137.1, 140.6, 143.5,
144.3, 164.7 ppm. FTIR: ν˜ = 695, 814, 1087, 1139, 1167, 1362, 1489,
1531, 1719, 2981 cm–1. HRMS (ESI-TOF) m/z: [M + H]+ calcd. for
C31H32N2O6S2 591.1624, found 591.1638.
Ethyl (E)-3-(4-Methyl-N-phenylbenzenesulfonamido)acrylate
(5): RF (silica gel, toluene): 0.12 (UV, KMnO4 solution). 1H NMR
[400 MHz, CDCl3]: δ = 1.24 (t, J = 7.1 Hz, 3 H), 2.44 (s, 3 H), 4.14 (q,
J = 7.1 Hz, 2 H), 4.62 (d, J = 13.8 Hz, 1 H), 6.88–6.97 (m, 2 H), 7.27–
7.32 (m, 2 H), 7.35–7.45 (m, 3 H), 7.53–7.60 (m, 2 H), 8.37 (d, J =
13.7 Hz, 1 H) ppm. 13C NMR [101 MHz, CDCl3]: δ = 14.3, 21.7, 60.1,
100.0, 121.7, 127.8, 129.7, 129.86, 129.89, 134.8, 135.1, 143.9, 144.9,
167.1 ppm. FTIR: ν˜ = 727, 906, 1089, 1170, 1368, 1624, 1737, 2245,
2981 cm–1. HRMS (ESI-TOF) m/z: [M + H]+ calcd. for C18H21NO4S
346.1113, found 346.1131.
General Procedure for the Intramolecular Hydroarylation of
Sulfonyl Ynamines 1a–c and 1g–k: Sulfonyl ynamine 1 (1.0 mmol,
1.0 equiv.) was dissolved in toluene (10 mL) under a nitrogen at-
mosphere in a Biotage microwave vial (10.0–20.0 mL) equipped
with a magnetic stirr ing bar. Pd(OAc)2 (11 mg, 0.05 mmol,
0.05 equiv.) and tri(p-tolyl)phosphine (30 mg, 0.1 mmol, 0.1 equiv.)
were added at 23 °C. The vial was covered with a Teflon septum and
secured via a crimped aluminum cap. The reaction was irradiated
in a Biotage Initiator microwave at 100 °C for 18 h (30 second pre-
stir, Fixed Hold Time On, Low absorbance level). The reaction mix-
ture was quenched with brine (50 mL) and extracted with AcOEt
(2 × 20 mL). The resulting organic washings were dried with sodium
sulfate, concentrated in vacuo and the crude residue was purified
by column chromatography as indicated.
Ethyl (E)-2-[5-Methyl-1,1-dioxo-2-phenyl-1,2-benzothiazol-
3(2H)-ylidene]acetate [(E)-2a]: (E)-1,2-Benzothiazoledione 2a was
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prepared according to general procedure using sulfonyl ynamine
1a (343 mg, 1.0 mmol). Ratio E/Z = 98:2 was determined by 1H
NMR spectroscopy. Column chromatography (toluene; silica gel was
washed with 1 % Et3N in heptane before being used for column
chromatography) afforded product (E)-2a as a white solid (127 mg,




dione 2b was prepared according to general procedure using sulf-
onyl ynamine 1b (355 mg, 1.0 mmol). Ratio E/Z >, 99:1 was deter-
mined by 1H NMR spectroscopy. Column chromatography (toluene;
silica gel was washed with 1 % Et3N in heptane before being used
for column chromatography) afforded the product (E)-2b as a white
solid (121 mg, 34 %). RF (silica gel, toluene): 0.28 (UV, KMnO4 solu-
tion). 1H NMR [400 MHz, CDCl3]: δ = 1.05 (s, 9 H), 2.57 (s, 3 H), 5.71
(s, 1 H), 7.48–7.53 (m, 2 H), 7.54–7.65 (m, 4 H), 7.82 (d, J = 7.9 Hz, 1
H), 9.10 (quint, J = 0.6 Hz, 1 H) ppm. 13C NMR [101 MHz, CDCl3]:
δ = 22.3, 26.8, 44.7, 101.5, 121.0, 127.8, 129.4, 130.4, 130.5, 130.6,
130.8, 130.9, 133.4, 145.1, 145.6, 204.3 ppm. FTIR: ν˜ = 695, 966,
1078, 1183, 1322, 1566, 1673, 2965 cm–1. HRMS (ESI-TOF) m/z: [M +
H]+ calcd. for C20H23NO3S 356.1320, found 356.1343.
(E)-2-[5-methyl-1,1-dioxo-2-phenyl-1,2-benzothiazol-3(2H)-ylid-
ene]-1-phenylethan-1-one [(E)-2c]: (E)-1,2-Benzothiazoledione 2c
was prepared according to general procedure using sulfonyl
ynamine 1c (375 mg, 1.0 mmol). Ratio E/Z = 98:2 was determined
by 1H NMR spectroscopy. Column chromatography (toluene; silica
gel was washed with 1 % Et3N in heptane before being used for
column chromatography) afforded the product (E)-2c as a white
solid (116 mg, 31 %). RF (silica gel, toluene): 0.31 (UV, KMnO4 solu-
tion). 1H NMR [400 MHz, CDCl3]: δ = 2.57 (s, 3 H), 6.09 (s, 1 H), 7.37–
7.45 (m, 2 H), 7.48–7.55 (m, 1 H), 7.56–7.66 (m, 6 H), 7.72–7.79 (m,
2 H), 7.85 (d, J = 8.0 Hz, 1 H), 9.00 (quint, J = 0.5 Hz, 1 H) ppm. 13C
NMR [101 MHz, CDCl3]: δ = 22.2, 102.4, 121.1, 127.4, 127.7, 128.2,
128.6, 129.1, 130.5, 130.6, 130.7, 130.9, 132.8, 133.6, 139.4, 145.1,
146.4, 189.7 ppm. FTIR: ν˜ = 696, 959, 1185, 1323, 1565, 1653, 1724,
2922, 3064 cm–1. HRMS (ESI-TOF) m/z : [M + H]+ calcd. for
C22H19NO3S 376.1007, found 376.1015.
Ethyl (E)-2-[1,1-Dioxo-2-phenyl-1,2-benzothiazol-3(2H)-
ylidene]acetate [(E)-2g]: (E)-1,2-Benzothiazoledione 2g was pre-
pared according to general procedure using sulfonyl ynamine 1g
(330 mg, 1.0 mmol). Ratio E/Z = 98:2 was determined by 1H NMR
spectroscopy. Column chromatography (toluene; silica gel was
washed with 1 % Et3N in heptane before being used for column
chromatography) afforded the product (E)-2g as a white solid
(112 mg, 34 %). RF (silica gel, toluene): 0.31 (UV, KMnO4 solution).
1H NMR [400 MHz, CDCl3]: δ = 1.28 (t, J = 7.1 Hz, 3 H), 4.20 (q, J =
7.1 Hz, 2 H), 5.16 (s, 1 H), 7.46–7.56 (m, 2 H), 7.57–7.67 (m, 3 H),
7.76–7.85 (m, 2 H), 7.92–8.02 (m, 1 H), 9.44 (m, 1 H) ppm. 13C NMR
[101 MHz, CDCl3]: δ = 14.4, 60.7, 97.6, 121.3, 127.4, 129.9, 130.5,
130.6, 130.7, 131.2, 132.5, 133.3, 133.9, 146.2, 166.3 ppm. FTIR: ν˜ =
692, 910, 1045, 1099, 1157, 1186, 1324, 1619, 1708, 2925 cm–1.
HRMS (ESI-TOF) m/z: [M + H]+ calcd. for C17H17NO4S 330.0800, found
330.0827.
Ethyl (E)-2-[5-Methoxy-1,1-dioxo-2-phenyl-1,2-benzothiazol-
3(2H)-ylidene]acetate [(E)-2h]: (E)-1,2-Benzothiazoledione 2h was
prepared according to general procedure using sulfonyl ynamine
1h (360 mg, 1.0 mmol). Ratio E/Z = 95:5 was determined by 1H
NMR spectroscopy. Column chromatography (toluene; silica gel was
washed with 1 % Et3N in heptane before being used for column
chromatography) afforded the product (E)-2h as a white solid
(119 mg, 33 %). RF (silica gel, toluene): 0.17 (UV, KMnO4 solution).
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1H NMR [400 MHz, CDCl3]: δ = 1.25 (t, J = 7.1 Hz, 3 H), 3.98 (s, 3 H),
4.16 (q, J = 7.1 Hz, 2 H), 5.12 (s, 1 H), 7.25 (dd, J = 8.7, 2.2 Hz, 1 H),
7.47–7.52 (m, 2 H), 7.53–7.64 (m, 3 H), 7.83 (d, J = 8.6 Hz, 1 H), 9.14
(d, J = 2.3 Hz, 1 H) ppm. 13C NMR [101 MHz, CDCl3]: δ = 14.3, 56.1,
60.5, 97.2, 113.4, 119.7, 122.4, 125.1, 129.6, 130.43, 130.49, 130.53,
131.0, 146.3, 164.0, 166.2 ppm. FTIR: ν˜ = 1103, 1183, 1252, 1307,
1473, 1583, 1621, 1707, 2988, 3118 cm–1. HRMS (ESI-TOF) m/z: [M +
H]+ calcd. for C18H19NO5S 360.0906, found 360.0919.
Ethyl (E)-2-[5-Nitro-1,1-dioxo-2-phenyl-1,2-benzothiazol-3(2H)-
ylidene]acetate [(E)-2i]: (E)-1,2-Benzothiazoledione 2i was pre-
pared according to general procedure using sulfonyl ynamine 1i
(375 mg, 1.0 mmol). Ratio E/Z >, 99:1 was determined by 1H NMR
spectroscopy. Column chromatography (toluene; silica gel was
washed with 1 % Et3N in heptane before being used for column
chromatography) afforded the product (E)-2i as a white solid
(113 mg, 30 %). RF (silica gel, toluene): 0.28 (UV, KMnO4 solution).
1H NMR [400 MHz, CDCl3]: δ = 1.28 (t, J = 7.1 Hz, 3 H), 4.24 (q, J =
7.1 Hz, 2 H), 5.27 (s, 1 H), 7.46–7.56 (m, 2 H), 7.58–7.69 (m, 3 H),
8.12 (d, J = 8.5 Hz, 1 H), 8.61 (dd, J = 8.5, 1.9 Hz, 1 H), 10.43 (d, J =
1.9 Hz, 1 H) ppm. 13C NMR [101 MHz, CDCl3]: δ = 14.2, 61.2, 99.9,
122.5, 125.6, 127.3, 129.1, 129.6, 130.7, 130.9, 131.1, 137.6, 143.8,
151.2, 165.6 ppm. FTIR: ν˜ = 694, 740, 1095, 1113, 1186, 1341, 1537,
1706, 2926, 3111 cm–1. HRMS (ESI-TOF) m/z: [M + H]+ calcd. for
C17H16N2O6S 375.0651, found 375.0667.
Ethyl (E)-2-[2,5-Dimethyl-1,1-dioxo-1,2-benzothiazol-3(2H)-yl-
idene]acetate [(E)-2j]: (E)-1,2-Benzothiazoledione 2j was prepared
according to general procedure using sulfonyl ynamine 1j (281 mg,
1.0 mmol). Ratio E/Z = 95:5 was determined by 1H NMR spectro-
scopy. Column chromatography (toluene; silica gel was washed with
1 % Et3N in heptane before being used for column chromatogra-
phy) afforded the product (E)-2j as colorless oil (87 mg, 31 %). RF
(silica gel, toluene): 0.23 (UV, KMnO4 solution). 1H NMR [400 MHz,
CDCl3]: δ = 1.35 (t, J = 7.1 Hz, 3 H), 2.54 (s, 3 H), 3.15 (s, 3 H), 4.25
(q, J = 7.1 Hz, 2 H), 5.33 (s, 1 H), 7.50 (d, J = 7.9 Hz, 1 H), 7.76 (d,
J = 7.9 Hz, 1 H), 9.17 (s, 1 H) ppm. 13C NMR [101 MHz, CDCl3]: δ =
14.3, 22.2, 26.5, 60.5, 95.0, 120.8, 127.9, 129.8, 130.5, 132.7, 144.8,
144.9, 166.0 ppm. FTIR: ν˜ = 701, 823, 1039, 1137, 1159, 1315, 1619,
1708, 2982 cm–1. HRMS (ESI-TOF) m/z : [M + H]+ calcd. for
C13H17NO4S 282.0800, found 282.0819.
Ethyl (E)-2-[2-Benzyl-5-methyl-1,1-dioxo-1,2-benzothiazol-
3(2H)-ylidene]acetate [(E)-2k] and Ethyl (E)-2-[2-(4-Methyl-
benzenesulfonyl)isoindolin-1-ylidene]acetate (6): (E)-1,2-Benzo-
thiazoledione 2k and compound 6 were prepared according to
general procedure using sulfonyl ynamine 1k (357 mg, 1.0 mmol).
Ratio E/Z >, 99:1 was determined by 1H NMR spectroscopy. Column
chromatography (toluene; silica gel was washed with 1 % Et3N in
heptane before being used for column chromatography) afforded
the product (E)-2k as a white solid (93 mg, 26 %) and product 6 as
a colorless oil (36 mg, 10 %). Compound (E)-2k: RF (silica gel, tolu-
ene): 0.30 (UV, KMnO4 solution). 1H NMR [400 MHz, CDCl3]: δ = 1.26
(t, J = 7.1 Hz, 3 H), 2.53 (s, 3 H), 4.15 (q, J = 7.1 Hz, 2 H), 4.84 (s, 2
H), 5.28 (s, 1 H), 7.27–7.33 (m, 1 H), 7.34–7.40 (m, 2 H), 7.40–7.44
(m, 2 H), 7.52 (dd, J = 7.9, 0.6 Hz, 1 H), 7.81 (d, J = 7.9 Hz, 1 H), 9.13
(quint, J = 0.6 Hz, 1 H) ppm. 13C NMR [101 MHz, CDCl3]: δ = 14.4,
22.4, 44.5, 60.6, 96.5, 121.0, 127.2, 127.8, 128.1, 129.1, 130.1, 130.4,
132.9, 134.1, 143.7, 145.1, 166.0 ppm. FTIR: ν˜ = 670, 732, 831, 1136,
1168, 1311, 1626, 1706, 2986, 3098 cm–1. HRMS (ESI-TOF) m/z: [M +
H]+ calcd. for C19H21NO4S 358.1113, found 358.1118. Compound 6:
RF (silica gel, toluene): 0.21 (UV, KMnO4 solution). 1H NMR [400 MHz,
CDCl3]: δ = 1.32 (t, J = 7.1 Hz, 3 H), 2.40 (s, 3 H), 4.19 (q, J = 7.1 Hz,
2 H), 5.02 (s, 2 H), 6.43 (s, 1 H), 7.28–7.39 (m, 4 H), 7.41–7.47 (m, 1
H), 7.76–7.83 (m, 2 H), 9.13 (d, J = 8.1 Hz, 1 H) ppm. 13C NMR
Full Paper
[101 MHz, CDCl3]: δ = 14.6, 21.8, 55.4, 60.1, 96.7, 121.9, 127.7, 128.4,
128.9, 130.1, 131.3, 133.0, 134.6, 138.1, 145.1, 152.0, 167.0 ppm.
FTIR: ν˜ = 667, 800, 1089, 1165, 1344, 1620, 1705, 2922 cm–1. HRMS
(ESI-TOF) m/z: [M + H]+ calcd. for C19H21NO4S 358.1113, found
358.1132.
Intramolecular Hydroarylation of 1d, 1e and 1f: Sulfonyl
ynamines 1d, 1e or 1f were submitted to the reaction conditions
according to general procedure. 1H NMR spectroscopy of the crude
product indicated partial degradation of the starting material to 4-
methyl-N-phenylbenzenesulfonamide 3 and additional unidentified
products. The formation of products 2d, 2e or 2f was not observed.
Study of Equilibration Between E- and Z-Isomers of 2a: (E)-1,2-
Benzothiazole-1,1-dione 2a or (Z)-1,2-Benzothiazole-1,1-dione 2a
(69 mg, 0.2 mmol, 1.0 equiv.) were independently dissolved in tolu-
ene (2 mL) under a nitrogen atmosphere in a Biotage microwave
vial (2.0–5.0 mL) equipped with a magnetic stirring bar. Pd(OAc)2
(2.2 mg, 0.01 mmol, 0.05 equiv.) and tri(p-tolyl)phosphine (6.1 mg,
0.02 mmol, 0.1 equiv.) were added at 23 °C. The vial was covered
with a Teflon septum and secured via a crimped aluminum cap. The
reaction was irradiated in a Biotage Initiator microwave at 100 °C
for 18 h (30 second pre-stir, Fixed Hold Time On, Low absorbance
level). The reaction mixture was quenched with brine (50 mL) and
extracted with AcOEt (2 × 20 mL). The combined organic washings
were dried with sodium sulfate, filtered off and concentrated in
vacuo. 1H NMR spectroscopy of the crude product indicated a mix-
ture of isomers with ratio E/Z = 85:15. Additionally, partial decom-
position of the starting material was observed.
General Procedure for Photochemical Rearrangement of 1,2-
Benzothiazole-1,1-diones: To 25 mL quartz flask was added 1,2-
benzothiazole-1,1-dione 2a, 2g, 2h or 2k (0.1–1.0 mmol, 1.0 equiv.)
in 10 mL of deoxygenated MeCN with stirring. This flask was irradi-
ated in a Rayonet RMR-600 photochemical reactor, using eight
lamps of 300 nm of wavelength for 24 h with internal temperature
of 50 °C. After cooling to 23 °C, the solvent was removed in vacuo
and the crude residue was purified by column chromatography as
indicated.
Ethyl 5-Methyl-1,1-dioxo-3-(phenylamino)-1-benzothiophene-
2-carboxylate (12a): 3-Amino-1-benzothiophene-1,1-dione 12a
was prepared according to general procedure using 1,2-benzothiaz-
ole-1,1-dione 2a (343 mg, 1.0 mmol). Column chromatography (tol-
uene; silica gel was washed with 1 % Et3N in heptane before being
used for column chromatography) afforded the product 12a as a
white solid (316 mg, 92 %). RF (silica gel, toluene): 0.22 (UV, KMnO4
solution). 1H NMR [400 MHz, CDCl3]: δ = 1.45 (t, J = 7.1 Hz, 3 H),
2.12 (s, 3 H), 4.43 (q, J = 7.1 Hz, 2 H), 6.40 (quint, J = 0.5 Hz, 1 H),
7.30–7.34 (m, 2 H), 7.39 (ddd, J = 7.8, 1.3, 0.7 Hz, 1 H), 7.44–7.54 (m,
3 H), 7.71 (d, J = 7.8 Hz, 1 H), 10.43 (br. s, 1 H) ppm. 13C NMR
[101 MHz, CDCl3]: δ = 14.4, 21.7, 61.1, 100.1, 121.2, 125.9, 126.5,
127.0, 128.6, 129.8, 133.6, 137.4, 138.2, 142.8, 155.0, 164.5 ppm.
FTIR: ν˜ = 704, 730, 1027, 1122, 1160, 1247, 1285, 1569, 1657, 2854,
2925 cm–1. HRMS (ESI-TOF) m/z: [M + H]+ calcd. for C18H19NO4S
344.0957, found 344.0963.
Ethyl 1,1-Dioxo-3-(phenylamino)-1-benzothiophene-2-carb-
oxylate (12b): 3-Amino-1-benzothiophene-1,1-dione 12b was pre-
pared according to general procedure using 1,2-benzothiazoledione
2g (33 mg, 0.1 mmol). Column chromatography (toluene; silica gel
was washed with 1 % Et3N in heptane before being used for column
chromatography) afforded the product 12b as a white solid (31 mg,
96 %). RF (silica gel, toluene): 0.24 (UV, KMnO4 solution). 1H NMR
[400 MHz, CDCl3]: δ = 1.45 (t, J = 7.1 Hz, 3 H), 4.44 (q, J = 7.1 Hz, 2
H), 6.66 (d, J = 8.0 Hz, 1 H), 7.23–7.28 (m, 1 H), 7.29–7.36 (m, 2 H),
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7.43–7.54 (m, 3 H), 7.58–7.62 (m, 1 H), 7.83 (d, J = 7.6 Hz, 1 H), 10.44
(br. s, 1 H) ppm. 13C NMR [101 MHz, CDCl3]: δ = 14.4, 61.3, 99.9,
121.6, 125.7, 125.9, 126.9, 128.7, 130.0, 132.1, 133.2, 137.4, 141.0,
154.8, 164.6 ppm. FTIR: ν˜ = 702, 763, 1161, 1246, 1284, 1434, 1561,
1610, 1657, 2854, 2925 cm–1. HRMS (ESI-TOF) m/z: [M + H]+ calcd.
for C17H17NO4S 330.0800, found 330.0813.
Ethyl 5-Methoxy-1,1-dioxo-3-(phenylamino)-1-benzothiophene-
carboxylate (12c): 3-Amino-1-benzothiophene-1,1-dione 12c was
prepared according to general procedure using 1,2-benzothiazole-
1,1-dione 2h (36 mg, 0.1 mmol). Column chromatography (toluene;
silica gel was washed with 1 % Et3N in heptane before being used
for column chromatography) afforded the product 12c as a white
solid (31 mg, 87 %). RF (silica gel, toluene): 0.20 (UV, KMnO4 solu-
tion). 1H NMR [400 MHz, CDCl3]: δ = 1.45 (t, J = 7.1 Hz, 3 H), 3.48
(s, 3 H), 4.43 (q, J = 7.1 Hz, 2 H), 6.13 (d, J = 2.2 Hz, 2 H), 7.04 (dd,
J = 8.5, 2.2 Hz, 1 H), 7.32–7.38 (m, 2 H), 7.44–7.53 (m, 3 H), 7.72 (d,
J = 8.5 Hz, 1 H), 10.41 (br. s, 1 H) ppm. 13C NMR [101 MHz, CDCl3]:
δ = 14.4, 55.4, 61.2, 100.7, 111.6, 118.3, 122.8, 127.2, 127.8, 128.8,
130.0, 132.7, 137.4, 154.4, 162.3, 164.5 ppm. FTIR: ν˜ = 703, 729, 910,
1021, 1162, 1245, 1567, 1655, 2926 cm–1. HRMS (ESI-TOF) m/z: [M +
H]+ calcd. for C18H19NO5S 360.0906, found 330.0927.
Ethyl 3-(Benzylamino)-5-methyl-1,1-dioxo-1-benzothiophene-2-
carboxylate (12d): 3-Amino-1-benzothiophene-1,1-dione 12d was
prepared according to general procedure using 1,2-benzothiazole-
1,1-dione 2k (36 mg, 0.1 mmol). Column chromatography (toluene;
silica gel was washed with 1 % Et3N in heptane before being used
for column chromatography) afforded the product 12d as a white
solid (34 mg, 95 %). RF (silica gel, toluene): 0.25 (UV, KMnO4 solu-
tion). 1H NMR [400 MHz, CDCl3]: δ = 1.40 (t, J = 7.1 Hz, 3 H), 2.40
(s, 3 H), 4.36 (q, J = 7.1 Hz, 2 H), 5.02 (d, J = 5.9 Hz, 2 H), 7.33–7.40
(m, 3 H), 7.40–7.46 (m, 2 H), 7.49 (d, J = 7.8 Hz, 1 H), 7.59 (s, 1 H),
7.77 (d, J = 7.8 Hz, 1 H), 9.44 (br. s, 1 H) ppm. 13C NMR [101 MHz,
CDCl3]: δ = 14.5, 22.2, 50.0, 61.0, 100.1, 121.2, 125.9, 126.5, 127.0,
128.6, 129.8, 133.6, 137.4, 138.2, 142.8, 154.9, 164.5 ppm. FTIR: ν˜ =
735, 786, 1141, 1216, 1268, 1577, 1659, 1738, 2925, 3254 cm–1.
HRMS (ESI-TOF) m/z: [M + H]+ calcd. for C19H21NO4S 358.1113, found
358.1133.
CCDC 1828629 (for 2a), 1828630 (for 12a), and 1828631 (for 12d)
contain the supplementary crystallographic data for this paper.
These data can be obtained free of charge from The Cambridge
Crystallographic Data Centre.
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